The themes Envista is part of, the highest-graded companies in its industry, and the companies in its sector whose grade rose recently.
Graded A or B and worth $2B or more: A first, then the largest.
Rose to A or B on a filing in the last 90 days, worth $2B or more: largest first.
De omzetaandelen zijn schattingen voor six months ended July 3, 2026, geen cijfers uit een ingediend rapport.
Dental implant systems and related products
Systems for replacing missing teeth, including implants, guided-surgery products, bone-regeneration materials, and tooth restorations. Brands include Nobel Biocare, Alpha-Bio Tec, and Implant Direct.
DTX Studio software
Software that helps dental professionals review patient images and plan implant procedures and restorations.
Orthodontic brackets, wires, and related products
Products orthodontists use to move teeth, including brackets, wires, tubes, bands, retainers, and laboratory products. Brands include Ormco and Damon.
Spark clear aligners
Removable clear trays used to straighten teeth, with software for planning and reviewing treatment.
Dental imaging equipment
Dental X-ray systems, digital sensors, and intraoral scanners used to capture images of patients’ teeth and mouths. Brands include DEXIS and i-CAT.
Dental consumables and infection-prevention products
Materials and tools used in routine dental care, including restorative materials, root-canal products, burs, bonding agents, cements, and surface disinfectants. Brands include Kerr, Sybron Endo, and Metrex.
Envista makes products used to diagnose, treat, and prevent problems with teeth and gums, and to improve smiles. It sells to general dentists, dental specialists, orthodontists, dental laboratories, and dental groups, directly and through distributors. Its products range from dental imaging and treatment-planning software to tooth-replacement systems, braces, restorative materials, root-canal products, and disinfectants.
Gebouwd uit de eigen deponeringen van Envista Holdings Corporation bij de Amerikaanse toezichthouder Securities and Exchange Commission (SEC). De cijfers zijn zoals gerapporteerd, met de historie per aandeel herrekend naar de huidige aandelenbasis. Dit beschrijft een bedrijf — het is geen beleggingsadvies en geen aanbeveling om iets te kopen of te verkopen.
NVST · NYSE · Healthcare · Medical Instruments and Supplies
US$ 24,66-2,5%slot 12 nov
Cijfers tot en met 2 oktober 2026, uit de 10-Q ingediend op 4 november 2026
Envista makes dental implants, orthodontic braces and clear aligners, dental imaging equipment and software, and materials used in dental care.
Just reported
From Envista's results release of 4 november 2026; its quarterly report has since been filed.
Actual
US$ 691,5M
+3,2% y/y
-5,3% q/q
Guided
—
No guide given
Actual
US$ 3,11
Guided
—
No guide given
EPS, adjusted: US$ 0,40
Actual
US$ 515,2M
Guided
—
No guide given
Full year 2026
Set against the company's own guidance and the same quarter a year earlier, not analysts' estimates, which we do not hold. Adjusted figures are the company's own non-GAAP measures, as stated in the release.
Grade B+
De balk onder de koers toont het cijfer op elke datum, alleen gebaseerd op de stukken die toen al openbaar waren.
Toont 2 van 28 kwartalen van de cijferhistorie van Envista Holdings Corporation. De andere 26 lopen terug tot februari 2020.